MMA
ZBH icon

Miracle Mile Advisors’s Zimmer Biomet ZBH Stock Holding History

Miracle Mile Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-8,243
Closed -$955K – 409
2020
Q2 		$955K Buy
+8,243
New +$950K 0.08% 180
2018
Q3 		– Sell
-5,150
Closed -$557K – 174
2018
Q2 		$557K Hold
5,150
– – 0.05% 111
2018
Q1 		$545K Buy
+5,150
New +$598K 0.06% 105

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Miracle Mile Advisors's ZBH Position: Q3 2020 in Review

Miracle Mile Advisors sold out of Zimmer Biomet (ZBH) in Q3 2020, closing a stake of 8,243 shares — an estimated $955K sold.

Miracle Mile Advisors first reported a position in ZBH in Q1 2018 and held it in 3 quarters. The position peaked at $955K in Q2 2020. 930 funds tracked by Wall St. Rank hold ZBH as of Q3 2020.

  • Miracle Mile Advisors reported no remaining Zimmer Biomet position as of Q3 2020 after selling out during the quarter.
  • Miracle Mile Advisors sold 8,243 Zimmer Biomet shares in Q3 2020, an estimated $955K.
  • Miracle Mile Advisors first reported a position in Zimmer Biomet in Q1 2018 and held it in 3 quarters.
  • Miracle Mile Advisors's Zimmer Biomet position peaked at $955K in Q2 2020.
  • 930 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2020.

Based on Miracle Mile Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.